Letter to the Editor August 16, 2004

Successful Treatment of Sexual Dysfunction With Dronabinol: A Case Report

Alen J. Salerian, MD

J Clin Psychiatry 2004;65(8):1146-1147

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: It has recently been demonstrated that venlafaxine, a serotonin-norepinephrine reuptake inhibitor, is effective for the treatment of premenstrual dysphoric disorder (PMDD).1,2 However, withdrawal reactions with venlafaxine have been reported. 3-7 Most of these withdrawal reactions were noted in patients with depressive disorder and associated with daily venlafaxine doses of 150 mg or more.